The Advocate for Institutional Investors, Third Quarter 2009
October 2009
"The Wrong Prescription? Revisiting the Justification for Poison Pills" by Mark Lebovitch
Related Professional
Related Document
- News Press Coverage: Williams Companies Stockholder Litigation Trial Challenging Novel Anti-Shareholder Corporate Governance Provision January 13, 2021 Learn More
- Events BLB&G Partner Mark Lebovitch to Speak at NYU Law's Institute for Corporate Governance & Finance Roundtable, "Poison Pills after Williams Cos." April 27, 2022 Learn More
- Publications "Acting-in-Concert Poison Pills: This Pill Comes With a Silencer" by Mark Lebovitch, Gregory V. Varallo, and Thomas James published by The New York Law Journal November 25, 2020 Learn More
- News Delaware Justices Affirm BLB&G's Post-Trial Win in Williams, Establishing Critical Delaware Legal Precedent on Poison Pills November 7, 2021 Learn More
- News Mark Lebovitch and Gregory V. Varallo Quoted in Law360 article, "Delaware's Appeal For Firms Outshines Virus Uncertainty" March 16, 2021 Learn More
- Awards Benchmark Litigation Shortlists Mark Lebovitch for Plaintiff Litigator of the Year Award February 8, 2022 Learn More
- Awards Benchmark Litigation Once Again Shortlists BLB&G Partner Mark Lebovitch for Plaintiff Litigator of the Year Award February 17, 2023 Learn More
- Events Mark Lebovitch Speaks At Sandpiper Partners Conference "SPACs, De-SPACs and SPAC Litigation: Current Developments, Litigation, Investigations, and What's on the Horizon?" September 28, 2021 Learn More
- Events BLB&G Partner Mark Lebovitch Will Serve as a Panelist at CII-NYU Corporate Governance Bootcamp on The Role of Institutional Investors in Shareholder Litigation November 19, 2021 Learn More